DEA schedule
Is darifenacin a controlled substance?
Federal schedule for darifenacin from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Darifenacin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and darifenacin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted darifenacin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 16 prescription listings from 8 labelers, none with a DEA schedule |
| DEA controlled substances list | darifenacin is not on the list |
Darifenacin NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 13668-203 | Darifenacin | tablet, extended release | 15 mg/1 | Torrent Pharmaceuticals Limited | None |
| 33342-277 | Darifenacin | tablet, extended release | 15 mg/1 | Macleods Pharmaceuticals Limited | None |
| 46708-224 | DARIFENACIN | tablet, extended release | 15 mg/1 | Alembic Pharmaceuticals Limited | None |
| 62332-224 | DARIFENACIN | tablet, extended release | 15 mg/1 | Alembic Pharmaceuticals Inc. | None |
| 69097-432 | Darifenacin | tablet, extended release | 15 mg/1 | Cipla USA Inc. | None |
| 72162-2571 | Darifenacin | tablet, extended release | 15 mg/1 | Bryant Ranch Prepack | None |
| 13668-202 | Darifenacin | tablet, extended release | 7.5 mg/1 | Torrent Pharmaceuticals Limited | None |
| 33342-276 | Darifenacin | tablet, extended release | 7.5 mg/1 | Macleods Pharmaceuticals Limited | None |
| 46708-223 | DARIFENACIN | tablet, extended release | 7.5 mg/1 | Alembic Pharmaceuticals Limited | None |
| 62332-223 | DARIFENACIN | tablet, extended release | 7.5 mg/1 | Alembic Pharmaceuticals Inc. | None |
| 69097-431 | Darifenacin | tablet, extended release | 7.5 mg/1 | Cipla USA Inc. | None |
| 72162-2570 | Darifenacin | tablet, extended release | 7.5 mg/1 | Bryant Ranch Prepack | None |
| 16571-768 | Darifenacin | tablet, film coated, extended release | 15 mg/1 | Rising Pharma Holdings, Inc. | None |
| 65862-862 | Darifenacin | tablet, film coated, extended release | 15 mg/1 | Aurobindo Pharma Limited | None |
| 16571-767 | Darifenacin | tablet, film coated, extended release | 7.5 mg/1 | Rising Pharma Holdings, Inc. | None |
| 65862-861 | Darifenacin | tablet, film coated, extended release | 7.5 mg/1 | Aurobindo Pharma Limited | None |
Questions
Is darifenacin a controlled substance?
No. Darifenacin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and darifenacin is not on the DEA controlled substances list.
Is darifenacin a narcotic?
No. Darifenacin is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Cholinergic Muscarinic Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.